Saeed, Omar <br/><br/>
Antiplatelet Therapy and Adverse Hematologic Events During Heart Mate II Support.  [electronic resource] 

 -  Circulation. Heart failure  Jan 2016 
 - e002296 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1941-3297 
<br/><br/><label>Standard No.: </label>10.1161/CIRCHEARTFAILURE.115.002296  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Anticoagulants--adverse effects<br/>Aspirin--adverse effects<br/>Chi-Square Distribution<br/>Dipyridamole--adverse effects<br/>Disease-Free Survival<br/>Drug Therapy, Combination<br/>Female<br/>Heart Failure--blood<br/>Heart-Assist Devices--adverse effects<br/>Hemorrhage--chemically induced<br/>Humans<br/>International Normalized Ratio<br/>Kaplan-Meier Estimate<br/>Linear Models<br/>Male<br/>Middle Aged<br/>Multivariate Analysis<br/>New York City--epidemiology<br/>Platelet Aggregation Inhibitors--adverse effects<br/>Prevalence<br/>Proportional Hazards Models<br/>Prosthesis Design<br/>Retrospective Studies<br/>Risk Assessment<br/>Risk Factors<br/>Thrombosis--diagnosis<br/>Time Factors<br/>Treatment Outcome<br/>Ventricular Function, Left<br/>Warfarin--adverse effects